CORDIS CASHEL

Manufacturer adverse-event records for CORDIS CASHEL come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2016–2026 · thin-book · elevated Death-code · injury-heavy

Volume signature

CORDIS CASHEL is a thinner MAUDE footprint

CORDIS CASHEL accounts for 4,718 FDA MAUDE reports (#383 of 434, thin-book tercile). Death-coded event_type share is 1.84% (elevated); Injury share 74.1% (injury-heavy).

What the volume reading shows for CORDIS CASHEL

The standout signal for CORDIS CASHEL is filing volume: 4,718 adverse-event reports in FDA MAUDE (#383 of 434, thin-book). Death-coded event_type share sits at 1.84% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Injury at 3,496 (74.1% of event_type total). Peak single-year volume reaches 1,678 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,718
Total Reports
87
Event-type Death
3,496
Injury Reports
20
Device Types

Event Types

Injury 3,496 (74.1%)
Malfunction 1,135 (24.1%)
Death 87 (1.8%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Life Threatening 2,502 (37.1%)
1,458 (21.6%)
R 720 (10.7%)
S 624 (9.3%)
L 492 (7.3%)
Hospitalization 478 (7.1%)
O 161 (2.4%)
Other 99 (1.5%)
Death 94 (1.4%)
Required Intervention 64 (0.9%)
Disability 23 (0.3%)
H 22 (0.3%)

Yearly Trend

16
2016: 19
17
2017: 1,014
18
2018: 1,624
19
2019: 1,678
20
2020: 312
21
2021: 5
22
2022: 16
23
2023: 25
24
2024: 22
25
2025: 2
26
2026: 1